Drug Information

Drug General Information
Drug ID
D05TMJ
Former ID
DNC006767
Drug Name
1-phenyl-3-(2-(pyridin-2-yl)quinazolin-4-yl)urea
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528290]
Formula
C20H15N5O
Canonical SMILES
C1=CC=C(C=C1)NC(=O)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=N4
InChI
1S/C20H15N5O/c26-20(22-14-8-2-1-3-9-14)25-18-15-10-4-5-11-16(15)23-19(24-18)17-12-6-7-13-21-17/h1-13H,(H2,22,23,24,25,26)
InChIKey
XZUXPDFYRHJJLN-UHFFFAOYSA-N
PubChem Compound ID
10712256
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [528290]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 528290J Med Chem. 2006 Jul 13;49(14):4085-97.Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.
Ref 528290J Med Chem. 2006 Jul 13;49(14):4085-97.Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.